North America Molecular Diagnostics Market
The North America Molecular Diagnostics Market size was valued at US$ 8,056.48 Mn in 2022 and is projected to reach US$ 20,740.38 Mn by 2030, growing at a CAGR of 12.5% during 2022 - 2030.
Report Coverage
- Disease Area: Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders
- Technology: Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization
- Product and Services: Assays & Kits, Instruments, Services & Software
- End User: Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes
US$ 8,056.48 Mn
Market size in 2022
US$ 20,740.38 Mn
Market Size by 2030
12.5%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Molecular Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Molecular Diagnostics Market Regional Analysis
6.2 North America Molecular Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 North America Molecular Diagnostics Market Forecast Analysis
7. North America Molecular Diagnostics Market Analysis – by Disease Area
7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Oncology: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Infectious Disease
- 7.2.1 Overview
- 7.2.2 Infectious Disease: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Genetic Testing
- 7.3.1 Overview
- 7.3.2 Genetic Testing: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Cardiac Diseases
- 7.4.1 Overview
- 7.4.2 Cardiac Diseases: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Immune System Disorders
- 7.5.1 Overview
- 7.5.2 Immune System Disorders: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Molecular Diagnostics Market Analysis – by Technology
8.1 Polymerase Chain Reaction
- 8.1.1 Overview
- 8.1.2 Polymerase Chain Reaction: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
- 8.2.1 Overview
- 8.2.2 Isothermal Nucleic Acid Amplification Technology: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 DNA Sequencing & Next-Generation Sequencing
- 8.3.1 Overview
- 8.3.2 DNA Sequencing & Next-Generation Sequencing: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 DNA Microarrays
- 8.4.1 Overview
- 8.4.2 DNA Microarrays: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 In-Situ Hybridization
- 8.5.1 Overview
- 8.5.2 In-Situ Hybridization: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Molecular Diagnostics Market Analysis – by Product and Services
9.1 Assays & Kits
- 9.1.1 Overview
- 9.1.2 Assays & Kits: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Instruments
- 9.2.1 Overview
- 9.2.2 Instruments: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Services & Software
- 9.3.1 Overview
- 9.3.2 Services & Software: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Molecular Diagnostics Market Analysis – by End User
10.1 Hospitals & Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals & Clinics: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Diagnostic Laboratories
- 10.2.1 Overview
- 10.2.2 Diagnostic Laboratories: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Research & Academic Institutes
- 10.3.1 Overview
- 10.3.2 Research & Academic Institutes: North America Molecular Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. North America Molecular Diagnostics Market – North America Analysis
11.1 Overview
11.2 North America- 11.2.1 North America Molecular Diagnostics Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 North America Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 US: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 US: North America Molecular Diagnostics Market Breakdown, by Disease Area
- 11.2.1.1.2 US: North America Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 US: North America Molecular Diagnostics Market Breakdown, by Product and Services
- 11.2.1.1.4 US: North America Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.2 Canada: North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Canada: North America Molecular Diagnostics Market Breakdown, by Disease Area
- 11.2.1.2.2 Canada: North America Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 Canada: North America Molecular Diagnostics Market Breakdown, by Product and Services
- 11.2.1.2.4 Canada: North America Molecular Diagnostics Market Breakdown, by End User
- 11.2.1.3 Mexico : North America Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Mexico : North America Molecular Diagnostics Market Breakdown, by Disease Area
- 11.2.1.3.2 Mexico : North America Molecular Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 Mexico : North America Molecular Diagnostics Market Breakdown, by Product and Services
- 11.2.1.3.4 Mexico : North America Molecular Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Agilent Technologies Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 bioMerieux SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Danaher
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 F. Hoffmann-La Roche Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Illumina Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Novartis AG
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Qiagen NV
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Siemens Healthineers AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 TBG Diagnostics Limited
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Thermo Fisher Scientific Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
